# Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)

> **NCT02088203** · PHASE1 · COMPLETED · sponsor: **Pennington Biomedical Research Center** · enrollment: 64 (actual)

## Conditions studied

- Diabetes Prevention

## Interventions

- **DIETARY_SUPPLEMENT:** Dose 1
- **DIETARY_SUPPLEMENT:** Dose 2
- **DIETARY_SUPPLEMENT:** Dose 0
- **DIETARY_SUPPLEMENT:** Dose 3
- **DIETARY_SUPPLEMENT:** Dose 4
- **DIETARY_SUPPLEMENT:** Dose 5
- **DIETARY_SUPPLEMENT:** Dose 6

## Key facts

- **NCT ID:** NCT02088203
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-03-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02088203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02088203, "Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02088203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*